Guo A. et al. showed that FGF19 promotes osteogenic differentiation by regulating the Wnt/β-catenin pathway to attenuate obesity and ageing-induced bone loss [18, 32]. This evidence concerns the gene FGF19 and obesity due to melanocortin 4 receptor deficiency.